… with spastic cerebral palsy treated with botulinum toxin reported in the last three years has led
… management of spastic cerebral palsy with the toxin, determine its indications, analyze the …

… spasticity and experience good results in the clinical measurements and in QOL after treatment
with botulinum toxin… in the developing fetal or infant brain” [1]. Multidisciplinary treatment …

… interesting results. There have been no systemic sideeffects and no cases of induced systemic
toxicity, … We have shown that botulinum toxin can objectively reduce spasticity in cerebral …

… limbs of children with cerebral palsy will result in a predictable … in the developing foetal or
infant brain. The motor disorders of … in developed countries [27, 31]. A widely used definition of …

… The objective of this study was to investigate the effects of botulinum toxin type A injections
… an improvement in subjectively rated management, appearance, and function. A case study …

… of spasticity management in children with cerebral palsy. It … This is the case in evaluation of
the effectiveness of selective … -designed trials to study the effects of the treatment options on …

… side effects such as dysphagia and ptosis of the eyelid, reported in adults during the treatment
of spasmodic torticollis [ 14,26,27] … Infant botulism: a review of 12 years’ experience at the …

… botulinum toxin A (BTX-A; Dysport®) in 125 patients (mean age 5.2 years, SD 2; 54% male)with
dynamic equinus spasticity … Results from these analyses were consistent with the result …

… We evaluated the effects of botulinum toxin type A (BTA) – … in the developing fetal or infant
brain. The motor disorders of … The prospective clinical study included 27 children, aged …

… IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type … case series included children
with a diagnosis of infantile … On the other hand, one of the main adverse effects reflected is …